Correlation Between Centessa Pharmaceuticals and BGC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and BGC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and BGC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and BGC Group, you can compare the effects of market volatilities on Centessa Pharmaceuticals and BGC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of BGC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and BGC.

Diversification Opportunities for Centessa Pharmaceuticals and BGC

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Centessa and BGC is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and BGC Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BGC Group and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with BGC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BGC Group has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and BGC go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and BGC

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.81 times more return on investment than BGC. However, Centessa Pharmaceuticals is 1.81 times more volatile than BGC Group. It trades about 0.09 of its potential returns per unit of risk. BGC Group is currently generating about 0.08 per unit of risk. If you would invest  388.00  in Centessa Pharmaceuticals PLC on August 30, 2024 and sell it today you would earn a total of  1,372  from holding Centessa Pharmaceuticals PLC or generate 353.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  BGC Group

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
BGC Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days BGC Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BGC is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Centessa Pharmaceuticals and BGC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and BGC

The main advantage of trading using opposite Centessa Pharmaceuticals and BGC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, BGC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BGC will offset losses from the drop in BGC's long position.
The idea behind Centessa Pharmaceuticals PLC and BGC Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio